Abstract:The countries of the Association of Southeast Asian Nations (ASEAN) have been dealing with dengue outbreaks for decades, being one of the regions with high dengue infection cases globally. These outbreaks are happening on top of the COVID-19 pandemic that is causing havoc among these ten countries. Both infectious diseases have caused a tremendous burden for the countries in the region-from infection control to the economic impact. This increasing number of cases happened with the contribution of the disruptio… Show more
“…According to the Indian database, approximately 7.03% of the total population has been fully vaccinated against COVID-19 with the first and second dose in late July 2021 [91,92]. In other ASEAN countries, Cambodia and Malaysia have the secondhighest rate of inoculation at 47%, followed by 11% and 7% in the Philippines and Vietnam of vaccination rates, respectively of the entire population [34,93]. Due to the shortage of vaccination, the under-health care system and other influencing factors such as misdiagnosis, false-positive results hinder the control of dengue and COVID-19 [94].…”
Section: Discussionmentioning
confidence: 99%
“…Few studies have shown the relationship between the impact of COVID-19 Lockdowns and social behaviour on the number of Dengue cases in different parts of the world including southeast Asian countries [32][33][34]. But the detailed and systematic analysis of the effect of COVID-19 lockdowns with respect to the social behavior of people on the number of dengue cases in different parts of the world during the pre-pandemic and pandemic of COVID-19 is still not well studied.…”
Background
The world has been battling several vector-borne diseases since time immemorial. Socio-economic marginality, precipitation variations and human behavioral attributes play a major role in the proliferation of these diseases. Lockdown and social distancing have affected social behavioral aspects of human life and somehow impact on the spread of vector borne diseases. This article sheds light into the relationship between COVID-19 lockdown and global dengue burden with special focus on India. It also focuses on the interconnection of the COVID-19 pandemic (waves 1 and 2) and the alteration of human behavioral patterns in dengue cases.
Methods
We performed a systematic search using various resources from different platforms and websites, such as Medline; Pubmed; PAHO; WHO; CDC; ECDC; Epidemiology Unit Ministry of Health (Sri Lanka Government); NASA; NVBDCP from 2015 until 2021. We have included many factors, such as different geographical conditions (tropical climate, semitropic and arid conditions); GDP rate (developed nations, developing nations, and underdeveloped nations). We also categorized our data in order to conform to COVID-19 duration from 2019 to 2021. Data was extracted for the complete duration of 10 years (2012 to 2021) from various countries with different geographical region (arid region, semitropic/semiarid region and tropical region).
Results
There was a noticeable reduction in dengue cases in underdeveloped (70–85%), developing (50–90%), and developed nations (75%) in the years 2019 and 2021. The dengue cases drastically reduced by 55–65% with the advent of COVID-19 s wave in the year 2021 across the globe.
Conclusions
At present, we can conclude that COVID-19 and dengue show an inverse relationship. These preliminary, data-based observations should guide clinical practice until more data are made public and basis for further medical research.
“…According to the Indian database, approximately 7.03% of the total population has been fully vaccinated against COVID-19 with the first and second dose in late July 2021 [91,92]. In other ASEAN countries, Cambodia and Malaysia have the secondhighest rate of inoculation at 47%, followed by 11% and 7% in the Philippines and Vietnam of vaccination rates, respectively of the entire population [34,93]. Due to the shortage of vaccination, the under-health care system and other influencing factors such as misdiagnosis, false-positive results hinder the control of dengue and COVID-19 [94].…”
Section: Discussionmentioning
confidence: 99%
“…Few studies have shown the relationship between the impact of COVID-19 Lockdowns and social behaviour on the number of Dengue cases in different parts of the world including southeast Asian countries [32][33][34]. But the detailed and systematic analysis of the effect of COVID-19 lockdowns with respect to the social behavior of people on the number of dengue cases in different parts of the world during the pre-pandemic and pandemic of COVID-19 is still not well studied.…”
Background
The world has been battling several vector-borne diseases since time immemorial. Socio-economic marginality, precipitation variations and human behavioral attributes play a major role in the proliferation of these diseases. Lockdown and social distancing have affected social behavioral aspects of human life and somehow impact on the spread of vector borne diseases. This article sheds light into the relationship between COVID-19 lockdown and global dengue burden with special focus on India. It also focuses on the interconnection of the COVID-19 pandemic (waves 1 and 2) and the alteration of human behavioral patterns in dengue cases.
Methods
We performed a systematic search using various resources from different platforms and websites, such as Medline; Pubmed; PAHO; WHO; CDC; ECDC; Epidemiology Unit Ministry of Health (Sri Lanka Government); NASA; NVBDCP from 2015 until 2021. We have included many factors, such as different geographical conditions (tropical climate, semitropic and arid conditions); GDP rate (developed nations, developing nations, and underdeveloped nations). We also categorized our data in order to conform to COVID-19 duration from 2019 to 2021. Data was extracted for the complete duration of 10 years (2012 to 2021) from various countries with different geographical region (arid region, semitropic/semiarid region and tropical region).
Results
There was a noticeable reduction in dengue cases in underdeveloped (70–85%), developing (50–90%), and developed nations (75%) in the years 2019 and 2021. The dengue cases drastically reduced by 55–65% with the advent of COVID-19 s wave in the year 2021 across the globe.
Conclusions
At present, we can conclude that COVID-19 and dengue show an inverse relationship. These preliminary, data-based observations should guide clinical practice until more data are made public and basis for further medical research.
“…In line with a previous literature review ( Mohd-Zaki et al, 2014), this review also found the incidence of dengue in Malaysia to be increasing, with the number of cases exceeding 80,000 annually between 2014-2019. During that period, 2019, a year of severe outbreaks in several countries in Southeast Asia (Cambodia, Indonesia, Lao PDR, Philippines, Thailand, and Vietnam), including Malaysia, recorded the highest dengue incidence (Wiyono et al, 2021), followed by 2015. The rising incidence of dengue is likely due to a number of compounding factors which include urbanisation, shifts in the dominant DENV serotype, vector expansion and climate change (temperature, humidity, and rainfall) which is favourable for breeding of Aedes spp.…”
“…Diagnosis remains difficult as febrile illnesses with common presentation are increasing globally [18]. There was a 46% increase in dengue cases from 2015 to 2019, with a prominent peak in 2019 from Association of Southeast Asian Nations (ASEAN) region [19]. More recent studies during the pre-COVID-19 period (2015-2019) and COVID-19 period (2020-2021) showed average dengue incidences across the 22 major dengue-endemic Asian countries including Nepal and Latin American countries decreasing by 16% during the pandemic period compared to the pre-COVID-19 time (2015-2019), although sporadic increases in the incidences were observed in some countries including Singapore [20].…”
Section: Discussionmentioning
confidence: 99%
“…More recent studies during the pre-COVID-19 period (2015–2019) and COVID-19 period (2020–2021) showed average dengue incidences across the 22 major dengue-endemic Asian countries including Nepal and Latin American countries decreasing by 16% during the pandemic period compared to the pre-COVID-19 time (2015–2019), although sporadic increases in the incidences were observed in some countries including Singapore [ 20 ]. A few cases of COVID-19 and dengue co-infection have been reported from Nepal and other dengue-endemic countries [ 11 , 19 ].…”
Following the report of the first COVID-19 case in Nepal on 23 January 2020, three major waves were documented between 2020 and 2021. By the end of July 2022, 986 596 cases of confirmed COVID-19 and 11 967 deaths had been reported and 70.5% of the population had received at least two doses of a COVID-19 vaccine. Prior to the pandemic, a large dengue virus (DENV) epidemic affected 68 out of 77 districts, with 17 932 cases and six deaths recorded in 2019. In contrast, the country's Epidemiology and Disease Control Division reported 530 and 540 dengue cases in the pandemic period (2020 and 2021), respectively. Furthermore, Kathmandu reported just 63 dengue cases during 2020 and 2021, significantly lower than the 1463 cases reported in 2019. Serological assay showed 3.2% positivity rates for anti-dengue immunoglobulin M antibodies during the pandemic period, contrasting with 26.9-40% prior to it. Real-time polymerase chain reaction for DENV showed a 0.5% positive rate during the COVID-19 pandemic which is far lower than the 57.0% recorded in 2019. Continuing analyses of dengue incidence and further strengthening of surveillance and collaboration at the regional and international levels are required to fully understand whether the reduction in dengue incidence/transmission were caused by movement restrictions during the COVID-19 pandemic.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.